Welcome to our dedicated page for Nu Skin Enter news (Ticker: NUS), a resource for investors and traders seeking the latest updates and insights on Nu Skin Enter stock.
Nu Skin Enterprises, Inc. (NYSE: NUS) is an integrated beauty and wellness company whose news flow centers on product innovation, device launches, financial performance and global expansion. The company’s public updates highlight its focus on beauty and wellness device systems, nutritional products and anti-aging brands sold through a dynamic affiliate opportunity platform in nearly 50 markets worldwide.
News about Nu Skin often includes announcements of quarterly and full-year financial results, where management discusses revenue, earnings per share, regional performance and non-GAAP metrics such as constant-currency revenue change and adjusted EPS. These releases are frequently accompanied by conference call and webcast details, giving context on operating trends, segment results for the Nu Skin and Rhyz businesses, and guidance ranges.
Another key category of NUS news involves product and technology developments. Recent communications have featured the introduction of Prysm iO, an AI-powered intelligent nutritional wellness platform that measures carotenoid levels through a non-invasive finger scan and connects with Prysm-certified supplements. Nu Skin also issues updates about its portfolio of beauty and wellness device systems and recognition from third parties, such as rankings from Euromonitor International Ltd. for at-home beauty and wellness device systems.
Investors and followers of NUS can also expect news on strategic initiatives, including pre-market and launch activities in emerging markets like India, and commentary on regional trends such as growth in Latin America. Conference participation, moderated fireside chats and strategy discussions at industry events are additional sources of information on the company’s direction. Bookmark this page to monitor Nu Skin’s earnings releases, device and product announcements, geographic expansion updates and other material developments reflected in its news coverage.
NU Skin Enterprises (NYSE: NUS) reported FY25 results with $370.3M revenue, adjusted net income $14.5M, and adjusted EPS $0.29. Results trailed Stonegate estimates modestly but hit the high end of EPS guidance.
Rhyz contributed $48.52M (Manufacturing $42.45M; Rhyz Other $6.07M). Nu Skin posted 77.6% gross margin and selling expense improved to 40.8% of the core business. Management cited margin expansion, a one-time tax benefit, and expansion into India; Prism iO rollout and India opening timelines target 1H26 pre-launch and full opening in 2H26. FY26 EPS guidance midpoint: $1.00.
Nu Skin (NYSE: NUS) reported Q4 2025 revenue of $370.3M (down 16.9%) and full-year 2025 revenue of $1.49B (down 14.3%). Fiscal 2025 EPS was $3.18 with more than 50% earnings growth year-over-year. Q4 gross margin improved to 70.7% and operating margin was 6.3%.
The company provided Q1 2026 revenue guidance of $320–$340M and full-year 2026 revenue guidance of $1.35–$1.50B with EPS of $0.80–$1.20. Management highlighted Prysm iO device rollout and India pre-market work as growth initiatives.
Nu Skin Enterprises (NYSE: NUS) declared a quarterly cash dividend of $0.06 per share. The dividend is payable on Mar. 11, 2026 to shareholders of record on Feb. 27, 2026.
This notice communicates the declared per-share amount, record date, and payment date for investors.
Nu Skin (NYSE: NUS) announced the relaunch of Dr. Joseph Chang’s bestselling book The Aging Myth with 15 years of additional research on measurable biology and cellular wellness.
The updated edition links expanded chapters on cellular resilience, oxidative stress, and measurable biomarkers to Nu Skin’s Prysm iO platform and ageLOC technologies. The digital edition is available today for $9.99 on major retailers.
Stonegate Capital Partners attended the ICR 2026 conference in Dallas on January 14, 2026, where it moderated a fireside chat with Nu Skin (NASDAQ: NUS). Stonegate also attended presentations from LifeVantage (LFVN), USANA (USNA), Beachbody (BODI) and Strauss Group (STRS), and observed an RSM panel on "cutting through the AI hype." The release notes common themes across retail, hybrid and DTC go-to-market models in nutrition, beauty and wellness sectors and points readers to the full announcement for images and bios.
Nu Skin Enterprises (NYSE:NUS) will release its fourth quarter and full year 2025 financial results after the market closes on Thursday, Feb. 12, 2026. The management team will host a conference call the same day at 5:00 p.m. ET to discuss recent results and upcoming business initiatives. A live webcast of the call and the financial presentation will be available on the company investor relations site at ir.nuskin.com. A replay will remain available through Thursday, Feb. 26, 2026.
Nu Skin (NYSE: NUS) announced that president and CEO Ryan Napierski will participate in a moderated fireside chat at the ICR Conference on Monday, Jan. 12, 2026 to discuss company strategy and the state of the business. The discussion will cover 2026 plans to launch the Prysm iO intelligent wellness device and growth opportunities in emerging markets, including India. The event will be webcast live at 1:30 p.m. ET, with an archive available on the company investor relations site through Monday, Jan. 26, 2026.
Nu Skin (NYSE: NUS) released its 2024 Social Impact and Sustainability Report outlining philanthropy and environmental progress. Highlights include $4.6 million donated globally, 1,400 children's heart surgeries performed in 2024 (part of >32,000 since 1999), and 30 million meals purchased and donated through Nourish the Children in 2024 (totaling >850 million since 2002).
On sustainability, Nu Skin reports reducing 8.5 tons of plastic and 1.4 tons of paper, using >24 tons of recycled plastic and 100% RSPO sourcing for palm ingredients, and a goal to make all product packaging recycled, recyclable, reusable, reduced or renewable by 2030. The company received 37 awards for sustainability and social impact.
Nu Skin (NYSE: NUS) launched Prysm iO, an AI-powered, portable skin-scanning platform that measures carotenoid antioxidant levels via a <15-second finger scan and delivers a personalized Prysm Score. Built on 20+ years of carotenoid research and a database of >21 million scans, Prysm iO uses patent-pending Spectral Rai Technology and AI algorithms. A Nu Skin randomized, double-blind, placebo-controlled study (n=46) reported 43–46% skin carotenoid increases over 12 weeks and serum increases of 44% vitamin C and 26% selenium. Device rollout: qualified brand representatives in Q4 2025, broader consumer availability in early to mid-2026.
NU Skin Enterprises (NYSE: NUS) reported Q3 2025 revenue $364.2M, adjusted net income $17.1M, and adjusted EPS $0.34, compared with Stonegate estimates of $374.2M, $14.7M and $0.30. Results were within guidance: revenue at the low end and EPS at the high end. Rhyz revenue totaled $51.6M (Manufacturing $47.6M; Rhyz Other $4.0M). The core Nu Skin business posted a 70.5% gross margin and company selling expense fell to 35.8% (41.7% in core). Management flagged double-digit Latin America growth, sequential segment improvement, and narrowed Q4 and full‑year 2025 guidance while preserving a focus on margins. Cash balance stood at $251.7M. Prysm iO limited preview is planned in late 4Q25; India pre‑market activity starts in 4Q25 ahead of a 2026 launch.